Medline closes IPO, trades at $42.78
By HME News Staff
Updated 10:01 AM CST, Mon December 29, 2025
NORTHFIELD, Ill. - Medline announced Dec. 18 that it closed its upsized initial public offering (IPO) of 248,439,654 shares of its Class A common stock at a public offering price of $29.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 32,405,172 shares of Class A common stock. Medline intends to use the proceeds (net of underwriting discounts) from the issuance of 179,000,000 shares to repay outstanding indebtedness under its senior secured term loan facilities and the remainder for general corporate purposes and to bear the expenses of the offering. Medline intends to use the proceeds (net of underwriting discounts) from the issuance of 37,034,482 shares and from the issuance of shares pursuant to the exercise by the underwriters of their option to purchase an additional 32,405,172 shares of Class A common stock to purchase or redeem an equivalent aggregate number of outstanding equity interests from certain of its pre-IPO owners. Medline started trading on the NASDAQ on Dec. 17 under the symbol “MDLN.” At press time, the company’s shares were trading at $42.78.
Comments